A superspeciality health care hospital
   

            Department of Genetic Medicine

    Triple Marker Test on Maternal Blood For 1st & 2nd Trimester Non-invasive Diagnosis of Down syndrome / Neural Tube Defects and Other Fetal Anomalies

    Wiping the tears 
    The Triple Test Protocol at Sir Ganga Ram Hospital. 
    What is the Sensitivity of This Protocol ? 
    When to Obtain Serum for Triple Screen? 
    What about Samples Collected in the First Trimester? 
    How to Send the Samples? 
    What is the cost of the test? 
    What Information Should Be Provided Along With the Samples? 
    Turn Around Time For Triple Test 

    Reporting Triple Test Results 

    Additional Testing- Amniocentesis, Chromosomes, A.F.P / Acetyl cholinestrase in Amniotic Fluid. 

    Limitations of Triple screen 

    Other Applications 
    Genetic Counseling Services 
    Other Available Testing Services 
    Whom to Contact for Further Information?

    Wiping the tears 

    Mothers who have given birth to children with Down syndrome invariably ask the question, with tears in their eyes, Doctor, could this not have been, diagnosed before birth? it could have been, provided the Triple Marker test and a careful ultrasound had been done.

    The opportunity now exists for the obstetrician to prevent the birth of children with Down syndrome and other chromosomal disorders as well those with neural tube defects and malformations. This can be done through a simple blood test during pregnancy - The Triple Marker Test.

    We are happy to inform you that at Sir Ganga Ram Hospital we have perfected the Triple Marker test for the Indian patients to reduce the burden of malformations and genetic diseases.

    The Triple Test Protocol at Sir Ganga Ram Hospital. 

    This is a non-invasive testing protocol, which improves the ability to determine the risk of fetal Down syndrome, spina bifida and other anomalies for pregnant women. Current international practice defines excessive risk as greater than the numerical risk of fetal Down syndrome for patients at age 35 years (1 : 380 live-born at term), and for spina bifida as risk greater than 1:150.

    Triple Marker test uses ELISA based assays for maternal serum alpha fetoprotein (AFP), Beta subunit of human chorionic gonadotropin (b-hcg) and unconjugated estriol (UEst), combined with patient specific data including age, weight, gestational age, number of fetuses, and demographics to calculate the numerical risk for fetal Down syndrome and neural tube defects. It uses a sophisticated software program called Alpha (developed by Professor Nicholas Waid of UK, undoubtedly the international leader in this area) to calculate this risk.

    A unique feature of this protocol is that median values for each of these markers at different gestations have been determined specific to the Indian population, as assayed in our laboratory. This improves the accuracy, sensitivity and specificity of the test. This is backed by genetic counselling both before and after the test, and amniocenteses if it becomes necessary, at an affordable price.

    What is the Sensitivity of This Protocol? 

     Testing these three markers produces test results twice as sensitive as those obtained from the use of AFP alone. Triple screen will detect 65% of fetal Down syndrome cases at a risk level of 1:380 (equivalent to the risk of a 35-year-old patient). The false positive rate is 5% (95% specificity). If the quadruple test is used the sensitivity of detection increases to 76%.

    Rationale for limiting the sensitivity to 65%.

    The sensitivity of the triple screen can be increased to 70 to 80%. However at this level, there is a dramatic increase (10 to 15%) in false positives, which could lead to unjustifiable doubling or tripling of amniocentesis procedures.

    When to Obtain Serum for Triple Screen? 

    Serum samples should be obtained in the second trimester from 15 to 22 weeks of gestation. Out side this gestational age range the sensitivity and specificity of the test are reduced, while in 1st trimester different markers are used.

    What about Samples Collected in the First Trimester? 

     For samples collected from 10 to 14 weeks of gestation different markers are used (PAPP-A, free beta hCG along with ultrasound to measure nuchal thickness). We have standardised these tests for first trimester, and can provide their analysis. The values of these two assays, combined with nuchal thickness as measured on ultrasound has an accuracy of 85% in detecting Down syndrome / other chromosomal disorders in the fetus. While there is debate over issues involved in choosing between first and second trimester screening the most effective screening test for Down syndrome is the integrated test (involving first and second trimester markers). This has a 94% detection rate for a 5% false positive rate.

    How to Send the Samples? 

    Three (3) ml of blood in a plain tube should be collected and sent to us. If samples are being sent from another city use a reliable courier so that the sample reaches within 48 hours, or get the serum separated by a local lab. No refrigeration is required. Use vacutainers if possible, as they do not leak. Keep the tubes in a small plastic box, which are available from any plastic ware shop.

    What is the Cost of the Test? 

     The cost of the test including the interpretation by the Alpha software is Rs. 800 for 2nd trimester screening (excludes genetic counselling and amniocentesis) and Rs. 1200 for 1st trimester tests.

    What Information Should Be Provided Along With the Samples? 

    Kindly provide the following information with the sample- name, date of birth of the woman, date of last menstrual period, weight, previous history of Down syndrome or neural tube defect, presence of diabetes mellitus or jaundice, and address where the results is to be sent. If you have a fax number or email address kindly provide the same.

    Turn Around Time For Triple Test 

    Test results are reported in a maximum of three working days from receipt of the specimen. 

Reporting Triple Test Results 

  1. Test result will be reported as Screen positive or negative. Screen positive means the risk of Down syndrome is more that 1 in 380 (risk of Down syndrome at age 35)

  2. The actual risk using the values of the three markers will be provided both for Down syndrome as well as neural tube defects.

Additional Testing- Amniocentesis, Chromosomes, A.F.P / Acetyl cholinestrase in Amniotic Fluid. 

    It has been our experience that amniocentesis for chromosomal studies and A.F.P / Acetyl Cholinestrase assay will be recommended for approximately 5% of patients evaluated by Triple Marker test. These tests are also available at our hospital. We are the first to offer amniotic cell culture and acetyl cholinestrase assay locally in Delhi.

    Limitations of Triple Screen 

  1. Triple marker test is not a diagnostic test for Down syndrome or other chromosomal disorders. It can be used only to calculate the probability or risk of this event.

  2. Triple marker test is not a substitute for amniocentesis or chorionic villus sampling which are required for a definitive diagnosis of Down syndrome or chromosomal disease. However, the latter are invasive tests with some risk of abortion, albiet small. The triple test will identify only 65% of probable Down syndrome cases.

  3. The current standard of care for pregnant women 35 years or older requires chorionic villus sampling or amniocentesis for a definitive diagnosis of fetal chromosomes. We prefer amniotic cell cultures in such a situation as the risk of abnormality is small (1-2%).

Other Applications 

    The Alpha software Program provides a risk of Trisomy 18 at the same time. However the sensitivity rates are lower than that achieved for Down syndrome. It also provides risk figures for 1st trimester screening.

Genetic Counseling Services 

    All reports are reviewed and signed by the senior consultant who has vast experience in application of this test. Genetic counselling services can be provided both before and after the test, at a flexible and convenient time for the patient, but on additional charge.

Other Available Testing Services

  • Chromosomal studies by amniocentesis or chorionic villus sampling, or on products of conception (POC). Sterility of the samples is essential. For POC collect in special medium or sterile glucose saline and store at 0-4c before dispatch. All these tests are done locally at reasonable rates.

  • Prenatal diagnosis by DNA technology of thalassemia, sickle cell disease, and Hb E; Duchenne muscular dystrophy, spinal muscular neural tube defects; Cystic fibrosis, achondroplasia, albimison  and  deafness (selected cases) and many other Genetic disorders.

  • Biochemical tests for Mental retardation in the new-born.

Whom to Contact for Further Information?

     For any further information or clarification you may contact Dr. I.C Verma or Dr. Rajesh Sharma at the Department of Medical Genetics, Sir Ganga Ram Hospital (Telphone 011-5821767).

Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110060, INDIA
Tel: 25735205, 25861463 Fax: 25861002 Email: gangaram@sgrh.com
The official website, created and maintained by Website Committee.  ©  1999-2007 All rights reserved